Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa
Open Access
- 4 March 2022
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (3) , 192
Abstract
Pseudomonas aeruginosa, one of the most intractable Gram-negative bacteria, has become a public health threat due to its outer polysaccharide layer, efflux transporter system, and high level of biofilm formation, all of which contribute to multi-drug resistance. Even though it is a pathogen of the highest concern, the status of the antibiotic development pipeline is unsatisfactory. In this review, we summarize marine natural products (MNPs) isolated from marine plants, animals, and microorganisms which possess unique structures and promising antibiotic activities against P. aeruginosa. In the last decade, nearly 80 such MNPs, ranging from polyketides to alkaloids, peptides, and terpenoids, have been discovered. Representative compounds exhibited impressive in vitro anti-P. aeruginosa activities with MIC values in the single-digit nanomolar range and in vivo efficacy in infectious mouse models. For some of the compounds, the preliminary structure-activity-relationship (SAR) and anti-bacterial mechanisms of selected compounds were introduced. Compounds that can disrupt biofilm formation or membrane integrity displayed potent inhibition of multi-resistant clinical P. aeruginosa isolates and could be considered as lead compounds for future development. Challenges on how to translate hits into useful candidates for clinical development are also proposed and discussed.Keywords
Funding Information
- National Natural Science Foundation of China (Nos. 4217060347 (Z. L.), 41830535 (C.-Y. W.) and 81874300 (C.-Y. W.))
This publication has 82 references indexed in Scilit:
- Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosisEuropean Respiratory Journal, 2012
- Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteriaFEMS Microbiology Reviews, 2012
- The Antibacterial ent-Eusynstyelamide B and Eusynstyelamides D, E, and F from the Arctic Bryozoan Tegella cf. spitzbergensisJournal of Natural Products, 2011
- Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic FibrosisJournal of Bacteriology, 2010
- Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopyNature Nanotechnology, 2010
- Myxinidin, A Novel Antimicrobial Peptide from the Epidermal Mucus of Hagfish, Myxine glutinosa L.Marine Biotechnology, 2009
- Macrolactins O–R, Glycosylated 24-Membered Lactones from Bacillus sp. AH159-1Journal of Natural Products, 2007
- Gene Expression and Localization of the Epinecidin-1 Antimicrobial Peptide in the Grouper ( Epinephelus coioides ), and Its Role in Protecting Fish Against Pathogenic InfectionDNA and Cell Biology, 2007
- The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter SpeciesClinical Infectious Diseases, 2006
- Establishment of infection: lessons from a versatile opportunistMicrobes and Infection, 2000